Aβ Levels in the Jugular Vein and High Molecular Weight Aβ Oligomer Levels in CSF Can Be Used as Biomarkers to Indicate the Anti-Amyloid Effect of IVIg for Alzheimer’s Disease

PLoS ONE - United States
doi 10.1371/journal.pone.0174630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Optimized-SopungSunkiwon, a Herbal Formula, Attenuates Aβ Oligomer-Induced Neurotoxicity in Alzheimer’s Disease Models

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2017English

The Effect of Cadmium on Aβ Levels in APP/PS1 Transgenic Mice

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Longitudinal Change in CSF Tau and Aβ Biomarkers for Up to 48 Months in ADNI

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

Elucidating Molecular Mass and Shape of a Neurotoxic Aβ Oligomer

ACS Chemical Neuroscience
BiochemistryMedicinePhysiologyCell BiologyCognitive Neuroscience
2014English

Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-Β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Β-Amyloid (Aβ)

Science-Business eXchange
2012English

Soluble Aβ Oligomer Production and Toxicity

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2011English

Β-Amyloid (Aβ)

Science-Business eXchange
2010English

ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Neuron
Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy